EMERYVILLE, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Thursday reported a third-quarter loss of $28.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Emeryville, California-based company said it had a loss of 24 cents. Earnings, adjusted for non-recurring costs, were 6 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 5 cents per share.

The biopharmaceutical company posted revenue of $108.3 million in the period.

Dynavax Technologies expects full-year revenue in the range of $375 million to $425 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX at https://www.zacks.com/ap/DVAX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News